Vulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark

Similar documents
Pathology of Coronary Artery Disease

Pathology of Vulnerable Plaque Angioplasty Summit 2005 TCT Asia Pacific, Seoul, April 28-30, 2005

Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion

High-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens

Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection

Assessment of Vulnerable Plaque by IVUS and VH-IVUS

Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging

Coronary Artery Thermography

Chapter 43 Noninvasive Coronary Plaque Imaging

Imaging Atheroma The quest for the Vulnerable Plaque

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

1st Department of Cardiology, University of Athens, Hippokration Hospital, Athens, Greece

MR Imaging of Atherosclerotic Plaques

The 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories

Assessment of plaque morphology by OCT in patients with ACS

From the Vulnerable Atherosclerotic Plaque to CAD Management

Can IVUS Define Plaque Features that Impact Patient Care?

Left main coronary artery (LMCA): The proximal segment

TVA_C02.qxd 8/8/06 10:27 AM Page 19 PART 2. Pathology

Failure of positive. Recanalization and CTO formation. TCFA rupture with (fatal) thrombotic occlusion. TCFA Lipid pool

Plaque Characteristics in Coronary Artery Disease. Chourmouzios Arampatzis MD, PhD, FESC

2yrs 2-6yrs >6yrs BMS 0% 22% 42% DES 29% 41% Nakazawa et al. J Am Coll Cardiol 2011;57:

State of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC

CT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA

04RC2. The biology of vulnerable plaques. Jozef L. Van Herck 1, Christiaan J. Vrints 1, Arnold G. Herman 2

Pathology of the Vulnerable Plaque

Assessment of vulnerable plaque by OCT

Ischemic heart disease

Cottrell Memorial Lecture. Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease?

as a Mechanism of Stent Failure

Acute Coronary Syndromes Compendium. Acute Coronary Syndromes: Pathology, Diagnosis, Genetics, Prevention, and Treatment

Usefulness of OCT during coronary intervention

USING NON -TRADITIONAL RISK MARKERS IN ASSESSING CV RISK

Innate Immunity in Atherosclerosis

IVUS Virtual Histology. Listening through Walls D. Geoffrey Vince, PhD The Cleveland Clinic Foundation

OCT Findings: Lesson from Stable vs Unstable Plaques

actually rupture! Challenges to the vulnerable plaque concept

Title for Paragraph Format Slide

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

Malaysian Healthy Ageing Society

OCT; Comparative Imaging Results with IVUS, VH and Angioscopy

A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience

Can We Identify Vulnerable Patients & Vulnerable Plaque?

This review will reconsider the current paradigm for

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers

Detection of carotid plaque neovascularization with Superb Micro-Vascular Imaging

OCT. molecular imaging J Jpn Coll Angiol, 2008, 48: molecular imaging MRI positron-emission tomography PET IMT

Catch-up Phenomenon: Insights from Pathology

Pathophysiology of Cardiovascular System. Dr. Hemn Hassan Othman, PhD

Insights in Thrombosis and In-Stent Restenosis

Review Article Optical Coherence Tomography Imaging in Acute Coronary Syndromes

Le espressioni della placca che preoccupano il clinico: progressione o vulnerabilità? CardioLUCCA Marzo 2017

Blood Vessels. Dr. Nabila Hamdi MD, PhD

Appearance of Lipid-Laden Intima and Neovascularization After Implantation of Bare-Metal Stents

Basic Mechanisms of Atherosclerosis and Plaque Rupture: Clinical Implications

Cardiovascular Research Foundation and Columbia University Medical Center, New York.

Sites of Atherosclerosis In order of Frequency

Plaque Imaging: What It Can Tell Us. Kenneth Snyder, MD, PhD L Nelson Hopkins MD FACS Elad Levy MD MBA FAHA FACS Adnan Siddiqui MD PhD

Assessment of Coronary Plaque Vulnerability with Optical Coherence Tomography

Coronary plaque erosion: a clinical case. Dr. Giampaolo Niccoli, MD, PhD, FESC Institute of Cardiology Catholic University, Rome, Italy

The aorta is an integral part of the cardiovascular system and should not be considered as just a conduit for blood supply from the heart to the

Chest pain and troponins on the acute take. J N Townend Queen Elizabeth Hospital Birmingham

Cardiac CT Angiography

The Severity of Coronary Atherosclerosis at Sites of Plaque Rupture With Occlusive Thrombosis

FFR and outcome: The mechanistic link

Tissue Characterization of Coronary Plaques Using Intravascular Ultrasound/Virtual Histology

CHAPTER (2) THE VULNERABLE PLAQUE

PoS(FISBH2006)019. Imaging Vulnerable Plaque A radionuclide approach. H. William Strauss, M.D. 1

Vascular disease. Structural evaluation of vascular disease. Goo-Yeong Cho, MD, PhD Seoul National University Bundang Hospital

Original Article Protein expression patterns and histologic characteristics of coronary atherosclerosis from sudden cardiac death

Gary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function

IVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea

Optical Coherence Tomography for Intracoronary Imaging

Quantitative Imaging of Transmural Vasa Vasorum Distribution in Aortas of ApoE -/- /LDL -/- Double Knockout Mice using Nano-CT

Ανάπτυξης Ευάλωτων Αθηρωματικών Πλακών

Management of Multivessel CAD: Stenting or CABG?

Measuring Natriuretic Peptides in Acute Coronary Syndromes

Assessment of vulnerable and unstable carotid atherosclerotic plaques on endarterectomy specimens

Coronary Artery Calcification

Myocardial Infarction

FESC, FACC, MAHA, MSCAI, MEAPSI, ESH

Histopathology: Vascular pathology

CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY. Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus

Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE

THE EFFECT OF CALCIFIED PLAQUE ON STRESS WITHIN A FIBROUS THIN CAP ATHEROMA IN AN ATHEROSCLEROTIC CORONARY ARTERY USING FINITE ELEMENT ANALYSIS (FEA)

Who Cares About the Past?

STABILITY Stabilization of Atherosclerotic plaque By Initiation of darapladib TherapY. Harvey D White on behalf of The STABILITY Investigators

PCSK9 Inhibitors and Modulators

Noninvasive Coronary Imaging: Plaque Imaging by MDCT

Non-invasive Plaque Imaging

Atherothrombosis and High-Risk Plaque Part I: Evolving Concepts

Vulnerable Plaque. Atherothrombosis

Imaging the Vulnerable Plaque. David A. Dowe, MD Atlantic Medical Imaging

Subclinical atherosclerosis in CVD: Risk stratification & management Raul Santos, MD

Multimodality Imaging Atlas of Coronary Atherosclerosis

Defining Plaque Composition by CTA: The Latest Tool to Monitor Therapy?

Coronary Artery Calcium Score

Coronary Artery Disease in the 21 st Century: An Integrated Approach Based on Science and Art

Transcription:

Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem or Systemic Disease Erling Falk, Denmark

Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem in a Systemic Disease Erling Falk, Denmark

Vulnerable Plaque Pathophysiology, Detection, and Intervention VPs: Local Problems in a Systemic Disease? Erling Falk, Denmark

Am J Cardiol 1990;65:2F-6F. Review

Atherosclerosis: chronic smoldering inflammation plaque composition Plaques causing >75% stenosis by histology Fibrosis 68% Necrosis 16% Infl: 8% Ca: 8% Roberts et al (Falk. JACC 2006;47:C7-12)

Seattle, March 18, 1999 N Engl J Med 1999 Jan;340:115-26

NEJM 2005 352:1685-95

Non-coronary atherosclerosis CHD risk equivalent NCEP ATP III, 2002

Non-coronary atherosclerosis CHD risk equivalent NCEP ATP III, 2002

Acute coronary syndrome very high risk Circulation 2004;110:227-239

Despite profound lipid lowering in ACS ¼ come back with a new event within 30 m PROVE IT TIMI 22: statin after stabilized ACS (standard) (intensive) Cannon et al. NEJM 2004:350:1495-504

Atherosclerosis systemic disease with focal manifestations VP Thrombosis Falk. JACC 2006;47:C7-12

Atherosclerosis systemic disease with focal manifestations VP Thrombosis VP/culprit One? Few? Many? Falk. JACC 2006;47:C7-12

Am J Cardiol 2006;98(suppl):3Q-9Q

Am J Cardiol 2006;98(suppl):3Q-9Q

Mauriello et al. JACC 2005;45:1585-93

Plaque rupture (14/16 thrombi = 87.5%) AMI <2 TCFA per patient 16 patients Mauriello et al. JACC 2005;45:1585-93

Plaque rupture (14/16 thrombi = 87.5%) AMI <2 TCFA per patient 16 patients Mauriello et al. JACC 2005;45:1585-93

<2 TCFA per patient

Despite profound lipid lowering in ACS ¼ come back with a new event within 30 m PROVE IT TIMI 22: statin after stabilized ACS (standard) (intensive) Cannon et al. NEJM 2004:350:1495-504

Plaque rupture in fatal CAD 2-3 per patient, including culprit Ruptured Plaques total +thrombus 47 patients 1 103 40 83 patients 2 211 102 1 Falk E. Br Heart J 1983;50:127-34 2 Frink RJ. J Inv Cardiol 1994;6:173-85

Plaque rupture in non-cardiac death, n=129 relatively rare (vs CAD) Atheroma-related disease Plaque Rupture no thrombus +thrombus 69 persons: no 6 ( 9%) 0 60 persons: + 10 (17%) 3 mural (5%) Davies MJ et al. Eur Heart J 1989;10:203-8

NEJM 1984;310:1137-40

115 thrombi in 74 patients 103 (90%) of these had plaque fissuring NEJM 1984;310:1137-40

Curr Opin Cardiol 2001;16:285-292

Plaque rupture CAD ~1.3 TCFA per patient Kolodgie,, Virmani. Curr Opin Cardiol 2001;16:285-292

Plaque rupture CAD ~1.3 TCFA per patient Kolodgie,, Virmani. Curr Opin Cardiol 2001;16:285-292

Thin-cap fibroatheroma & rupture prox LAD: hot spot TCFA Plaque Rupture Healed Rupture Kolodgie,, Virmani. Curr Opin Cardiol 2001;16:285-292

LAD

VP and ruptured plaques relatively infrequent limited, focal distribution AHA, Nov 2006; abstract 251

VP and ruptured plaques relatively infrequent limited, focal distribution 50 hearts (33 CVD) TCFA, Vulnerable Plaque n=23 (0.46 per heart) Ruptured plaques n=19 (0.38 per heart) AHA, Nov 2006; abstract 251

Targeting Vulnerable Plaque medical whack-a-mole? Thrombosis-prone plaques 1. Origin speed of development 2. How long does a VP persist? 3. Fate healing without thrombosis silent rupture/thrombosis acute ischemic event (ACS, stroke)

Targeting Vulnerable Plaque medical whack-a-mole? Thrombosis-prone plaques 1. Origin speed of development 2. How long does a VP persist? 3. Fate healing without thrombosis silent rupture/thrombosis acute ischemic event (ACS, stroke) Acne. NEJM 2005;352:1463-72

Plaque Rupture Coronary Thrombosis men ~80% women ~60% Plaque rupture

Thrombosis-prone = high-risk = vulnerable plaque Coronary Thrombosis plaque rupture men ~80% women ~60% Ruptured Fatal Coronary Thrombi Precipitated by Plaque Rupture Non-ruptured Total AMI + SCD 1,460 1,114 = 76% Worldwide Falk. JACC 2006;47:C7-12

Coronary Atherosclerosis ruptured vs intact plaque Ruptured Intact lumen

Coronary Atherosclerosis ruptured vs intact plaque Plaque size Ruptured Intact lumen

Circulation 1996;94:2662-6

Circulation 1996;94:2662-6 ANGIOGRAPHY luminal narrowing (diameter reduction) IVUS/HISTOLOGY wall disease (plaque) B: Wall: 50% X-sectional Lumen: normal

Circulation 1996;94:2662-6 ANGIOGRAPHY luminal narrowing (diameter reduction) IVUS/HISTOLOGY wall disease (plaque) B: Wall: 50% X-sectional Lumen: normal

core Coronary Atherosclerosis ruptured vs intact plaque Plaque size Necrotic core ~34% of plaque area * ~3.8 mm 2 & ~9 mm long * Ruptured Intact lumen *Kolodgie, Virmani et al. Heart 2004;90:1385-91

% of plaque area 70 60 50 40 Coronary Plaque Rupture necrotic core in intact (stenotic) vs ruptured plaques 30 20 10 0 12% Intact 32% Ruptured Fibrosis Necrotic Core Calcium Gertz SD, Roberts WC. Am J Cardiol 1990;66:1368-72

Heart 2004;90:1385-91 Mean (SD) (stenotic)

Heart 2004;90:1385-91 Mean (SD) (stenotic) Overlap: Necrotic core >10% of an average stable plaque

Ruptured core Coronary Atherosclerosis ruptured vs intact plaque Plaque size Necrotic core ~34% of plaque area * ~3.8 mm 2 & ~9 mm long * Fibrous cap thinkness,, ~23 µm (95% <65 (95% <65 µm) * cap Intact lumen *Kolodgie, Virmani et al. Heart 2004;90:1385-91

Mean (SD) Heart 2004;90:1385-91

Coronary Atherosclerosis ruptured vs intact plaque Ruptured core Plaque size Necrotic core ~34% of plaque area * ~3.8 mm 2 & ~9 mm long * Fibrous cap thinkness,, ~23 µm (95% <65 macrophages, ~26% of cap * (95% <65 µm) * cap Intact lumen *Kolodgie, Virmani et al. Heart 2004;90:1385-91

Ruptured acellular hypocellular 26% 26% Coronary Atherosclerosis ruptured vs intact plaque Plaque size Necrotic core ~34% of plaque area * ~3.8 mm 2 & ~9 mm long * Fibrous cap thinkness,, ~23 µm (95% <65 macrophages, ~26% of cap * (95% <65 µm) * cap Ca core Intact fibrosis lumen *Kolodgie, Virmani et al. Heart 2004;90:1385-91

Mean ~ SD Lp-PLA 2 Kolodgie,, Virmani. Lp-associated PLA 2. ATVB 2006;26:2523-9

Heart 1996;76:312-6

Plaque inflammation: considerable overlap (dis)similar syndromes Considerable overlap between 1. Chr. stable angina, n=28 2. Unstable angina, n=18 3. Acute rest angina, n=12 van der Wal et al. Heart 1996;76:312-6

Mean ~ SD Lp-PLA 2 Kolodgie,, Virmani. Lp-associated PLA 2. ATVB 2006;26:2523-9

Mean ~ SD Lp-PLA 2 Kolodgie,, Virmani. Lp-associated PLA 2. ATVB 2006;26:2523-9

Mean ~ SD Lp-PLA 2 Kolodgie,, Virmani. Lp-associated PLA 2. ATVB 2006;26:2523-9

Mean ~ SD Lp-PLA 2 Kolodgie,, Virmani. Lp-associated PLA 2. ATVB 2006;26:2523-9

AHA Nov 2006

AHA Nov 2006 TCFA+RP relationship Plaque component predictor bivariate plaque size + + necrotic core size + + inflammation (macr) + - Conclusion: Plaque area and necrotic core determine the likelihood of plaque rupture

Plaque rupture: role of inflammation thrombus necrotic core

Plaque rupture: role of inflammation thrombus necrotic core

Plaque rupture: role of inflammation cap cap macrophages at rupture site (MMP, TF)

Coronary Atherosclerosis ruptured vs intact plaque Ruptured core cap Plaque size Necrotic core ~34% of plaque area * ~3.8 mm 2 & ~9 mm long * Fibrous cap thinkness,, ~23 µm (95% <65 macrophages,, ~26% of cap * smooth muscle cells (apoptosis) (95% <65 µm) * Intact lumen

Coronary Atherosclerosis ruptured vs intact plaque Ruptured core cap Plaque size Necrotic core ~34% of plaque area * ~3.8 mm 2 & ~9 mm long * Fibrous cap thinkness,, ~23 µm (95% <65 macrophages,, ~26% of cap * smooth muscle cells (apoptosis) % of plaque/cap 60 (95% <65 µm) * 50 40 30 Aorta Intact lumen 20 10 0 Core Cap Macr Cap SMC Stable Vulnerable Disrupted Davies et al. Br Heart J 1993;69:377-81

Mean (SD) Heart 2004;90:1385-91

Coronary Atherosclerosis ruptured vs intact plaque Ruptured core thrombus cap Plaque size Necrotic core ~34% of plaque area * ~3.8 mm 2 & ~9 mm long * Fibrous cap thinkness,, ~23 µm (95% <65 macrophages,, ~26% of cap * smooth muscle cells (apoptosis) thrombus Fatal Coronary Thrombi Precipitated by Plaque Rupture (95% <65 µm) * Intact lumen Total AMI + SCD 1,460 1,114 = 76% Worldwide Falk. JACC 2006;47:C7-12

Coronary Atherosclerosis ruptured vs intact plaque Ruptured core thrombus cap Plaque size Necrotic core ~34% of plaque area * ~3.8 mm 2 & ~9 mm long * Fibrous cap thinkness,, ~23 µm (95% <65 macrophages,, ~26% of cap * smooth muscle cells (apoptosis) thrombus (95% <65 µm) * Expansive remodeling Intact lumen *Kolodgie, Virmani et al. Heart 2004;90:1385-91

No correlation! Circ 1996; 94:928-31

Coronary Remodeling & Plaque Vulnerability positive but weak correlation with lipid core and macr Varnava, Mills, Davies. Circ 2002;105:939-43

Coronary Remodeling & Plaque Vulnerability positive but weak correlation with lipid core and macr Varnava, Mills, Davies. Circ 2002;105:939-43

Coronary Atherosclerosis ruptured vs intact plaque Ruptured core thrombus cap Plaque size Necrotic core ~34% of plaque area * ~3.8 mm 2 & ~9 mm long * Fibrous cap thinkness,, ~23 µm (95% <65 macrophages,, ~26% of cap * smooth muscle cells (apoptosis) thrombus (95% <65 µm) * Expansive remodeling Angiogenesis intraplaque hemorrhage Intact lumen *Kolodgie, Virmani et al. Heart 2004;90:1385-91

plaque LAD lumen vasa vasorum vasa vasorum Barger et al. Panels C & D, with further filling: Rich capillary network confined to the plaque, = adventitia-derived neovascularization A B neo- vascularization Leaky exudation Fragile hemorrhage neo- vascularization Lower edge of plaque C D

NEJM 2003 Dec;349:2316-25

Human Pathol 1995;26:450-6

Human Pathol 2005;36;330-40

Coronary Atherosclerosis ruptured vs intact plaque Ruptured core thrombus cap Plaque size Necrotic core ~34% of plaque area * ~3.8 mm 2 & ~9 mm long * Fibrous cap thinkness,, ~23 µm (95% <65 macrophages,, ~26% of cap * smooth muscle cells (apoptosis) thrombus (95% <65 µm) * Expansive remodeling Angiogenesis intraplaque hemorrhage Perivascular inflammation Intact lumen *Kolodgie, Virmani et al. Heart 2004;90:1385-91

Adventitial lymphocyte infiltration Lymphocytes Plaque (AHA Type V) HE Søren Dalager Adv. Media LAD, 50 F Died of AMI

AHA Nov 2006

Coronary Atherosclerosis ruptured vs intact plaque Ruptured Intact Ca core thrombus cap lumen Plaque size Necrotic core ~34% of plaque area * ~3.8 mm 2 & ~9 mm long * Fibrous cap thinkness,, ~23 µm (95% <65 macrophages,, ~26% of cap * smooth muscle cells (apoptosis) thrombus (95% <65 µm) * Expansive remodeling Angiogenesis intraplaque hemorrhage Perivascular inflammation Calcification & spotty *Kolodgie, Virmani et al. Heart 2004;90:1385-91

Coronary Plaque Rupture calcification in intact (stenotic) vs ruptured plaques % of plaque area 70 60 50 40 30 20 10 0 Intact 15% 5% Ruptured Fibrosis Necrotic Core Calcium Gertz SD, Roberts WC. Am J Cardiol 1990;66:1368-72

Coronary Atherosclerosis ruptured vs intact plaque Ruptured Intact Ca core thrombus cap lumen Plaque size Necrotic core ~34% of plaque area * ~3.8 mm 2 & ~9 mm long * Fibrous cap thinkness,, ~23 µm (95% <65 macrophages,, ~26% of cap * smooth muscle cells (apoptosis) thrombus (95% <65 µm) * Expansive remodeling Angiogenesis intraplaque hemorrhage Perivascular inflammation Calcification & spotty *Kolodgie, Virmani et al. Heart 2004;90:1385-91

Coronary Atherosclerosis targets for imaging Ruptured Intact Ca core thrombus cap lumen Plaque size Necrotic core ~34% of plaque area * ~3.8 mm 2 & ~9 mm long * Fibrous cap thinkness,, ~23 µm (95% <65 macrophages,, ~26% of cap * smooth muscle cells (apoptosis) thrombus (95% <65 µm) * Expansive remodeling Angiogenesis intraplaque hemorrhage Perivascular inflammation Calcification & spotty *Kolodgie, Virmani et al. Heart 2004;90:1385-91

Madjid et al. ATVB 2004;24:1775-82

Circulation 2006;114:2390-2411

TCFA = thin-cap fibroatheroma (the most frequent VP) Circulation 2006;114:2390-2411

TCFA = thin-cap fibroatheroma (the most frequent VP) Circulation 2006;114:2390-2411